Purdue Pharma director grilled on proposed opioid settlement
By GEOFF MULVIHILL Associated Press NEW YORK (AP) — Purdue Pharma’s quest to settle thousands of lawsuits over OxyContin’s toll has entered its final phase with the grudging acceptance of most of those who have claims against the company. A confirmation hearing opened in U.S. Bankruptcy Court on Thursday for a deal that removes control
Continue Reading